Article

Molecular imaging using labeled donor tissues reveals patterns of engraftment, rejection, and survival in transplantation.

Department of Pediatrics, Stanford School of Medicine, Stanford, California, USA.
Transplantation (Impact Factor: 3.78). 08/2005; 80(1):134-9. DOI: 10.1097/01.TP.0000164347.50559.A3
Source: PubMed

ABSTRACT Tissue regeneration and transplantation of solid organs involve complex processes that can only be studied in the context of the living organism, and methods of analyzing these processes in vivo are essential for development of effective transplantation and regeneration procedures. We utilized in vivo bioluminescence imaging (BLI) to noninvasively visualize engraftment, survival, and rejection of transplanted tissues from a transgenic donor mouse that constitutively expresses luciferase. Dynamic early events of hematopoietic reconstitution were accessible and engraftment from as few as 200 transplanted whole bone marrow (BM) cells resulted in bioluminescent foci in lethally irradiated, syngeneic recipients. The transplantation of autologous pancreatic Langerhans islets and of allogeneic heart revealed the tempo of transplant degeneration or immune rejection over time. This imaging approach is sensitive and reproducible, permits study of the dynamic range of the entire process of transplantation, and will greatly enhance studies across various disciplines involving transplantation.

0 Bookmarks
 · 
155 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: miR-21 is highly expressed in a variety of cancers, suggesting that it might play a role in the process of oncogenesis, as supported by it directly causing pre-B cell lymphomas in transgenic mice. Rm21LG transgenic mice for the conditional co-expression of miR-21 and luciferase (Luc) mediated by Cre/lox P system were generated. The homozygous Rm21LG transgenic mice were visually and readily characterized immediately after birth by whole-body fluorescence imaging. More importantly, miR-21 and Luc were successfully activated in the liver of Rm21LG/Alb-Cre double-transgenic mice, demonstrating that Rm21LG conditional transgenic system could work in a Cre-dependent manner. The combined use of this conditional miR-21 transgenic mouse line, various cell/tissue-specific Cre mouse lines and bioluminescence imaging will be a valuable tool in vivo to uncover the functions of miR-21 as oncomiR in initiating tumors.
    Biotechnology Letters 09/2013; · 1.85 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background Relatively little information exists regarding the usefulness of bone marrow-derived cells for skeletal muscle ischemia reperfusion injury ( I/R), especially when compared to I/R that occurs in other tissues. The objectives of this study were to evaluate the ability of freshly isolated bone marrow cells to home to injured skeletal muscle and to determine their effects on muscle regeneration. Materials and Methods Freshly isolated lineage-depleted bone marrow cells (Lin- BMCs) were injected intravenously 2 days after I/R. Bioluminescent imaging was used to evaluate cell localization for up to 28 days after injury. Muscle function, the percentage of fibers with centrally located nuclei, and the capillary to fiber ratio were evaluated 14 days after delivery of either saline (Saline) or saline containing Lin- BMCs (Lin- BMCs). Results Bioluminescence was higher in the injured leg than the contralateral control leg for up to 7 days after injection (p < 0.05) suggestive of cell homing to the injured skeletal muscle. Fourteen days after injury there was a significant improvement in maximal tetanic torque (40% vs. 22% deficit; p < 0.05), a faster rate of force production (+dP/dt) (123.6 vs 94.5 Nmm/S; p < 0.05), and a reduction in the percentage of fibers containing centrally located nuclei (40 vs 17%; p < 0.05), but no change in the capillary to fiber ratio in the Lin- BMC as compared to the Saline group. Conclusion The homing of freshly isolated BMCs to injured skeletal muscle following I/R is associated with an increase in functional outcomes.
    Journal of Surgical Research 01/2014; · 2.02 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: A water-soluble ionizing radiation mitigator would have considerable advantages for the management of acute and chronic effects of ionizing radiation. We report that a novel oxetanyl sulfoxide (MMS350) is effective both as a protector and a mitigator of clonal mouse bone marrow stromal cell lines in vitro, and is an effective in vivo mitigator when administered 24 h after 9.5 Gy (LD100/30) total-body irradiation of C57BL/6NHsd mice, significantly improving survival (P = 0.0097). Furthermore, MMS350 (400 μM) added weekly to drinking water after 20 Gy thoracic irradiation significantly decreased: expression of pulmonary inflammatory and profibrotic gene transcripts and proteins; migration into the lungs of bone marrow origin luciferase+/GFP+ (luc+/GFP+) fibroblast progenitors (in both luc+ marrow chimeric and luc+ stromal cell line injected mouse models) and decreased radiation-induced pulmonary fibrosis (P < 0.0001). This nontoxic and orally administered small molecule may be an effective therapeutic in clinical radiotherapy and as a counter measure against the acute and chronic effects of ionizing radiation.
    Radiation Research 10/2013; · 2.70 Impact Factor

Full-text (2 Sources)

View
27 Downloads
Available from
Jun 1, 2014